What is tucatinib/tucatinib?

Tucatinib/Tucatinib is a targeted anti-cancer drug used in combination with other drugs to treat advanced cancer breast cancer. Tucatinib belongs to a class of drugs called tyrosine kinase inhibitors. Tucatinib targets HER2 (human epidermal growth factor receptor 2) tyrosine kinase. HER2The receptor is involved in the growth and repair of normal breast cells. But between 10% and 20% of breast cancers have a defective HER2 gene that makes too many copies of itself. This results in the HER2protein being overexpressed-There are too many HER2receptors on the breast cells -This allows the breast cells to grow and divide uncontrollably.

Tucatinib works by blockingHER2 activity, which helps slow the growth and spread of cancer cells. Tucatinib is used in combination with trastuzumab and capecitabine because this combination helps patients live longer without their cancer progressing and live longer overall. Tucatinib was approved by the U.S. Food and Drug Administration (FDA) in 2020.

Take tucatinib strictly according to the recommendations of your medical staff. Tucatinib is used with the drugs trastuzumab and capecitabine. Your doctor will tell you the dosage of trastuzumab and capecitabine you will be taking and how you will receive it. Take tucatinib 2 times daily, with or without food. Take tucatinib approximately 12 hours apart or at the same time every day. Swallow the tucatinib tablet whole. Do not chew, crush, or split tucatinib tablets before swallowing. Do not use tucatinib tablets if they are broken, cracked, or damaged. There is a generic version of this drug in Bangladesh. The retail price of Everest Pharmaceuticals in Bangladesh is about 150mg30 tablets6000 yuan. The retail price of Ziska Pharmaceuticals in Bangladesh is around 4,500 yuan for 150 mg 30 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.